SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-092813
Filing Date
2023-12-04
Accepted
2023-12-04 17:25:58
Documents
1
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 1499
  Complete submission text file 0001213900-23-092813.txt   2816
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Issuer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 WESTWIND ROAD ANDOVER MA 01810
Business Address
Patane Michael A (Reporting) CIK: 0002002987 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39102 | Film No.: 231464440